SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-150209
Filing Date
2020-05-22
Accepted
2020-05-22 16:52:10
Documents
15
Period of Report
2020-05-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d934317d8k.htm   iXBRL 8-K 31799
2 EX-1.1 d934317dex11.htm EX-1.1 205726
3 EX-5.1 d934317dex51.htm EX-5.1 8009
7 GRAPHIC g934317g0522114454087.jpg GRAPHIC 2421
  Complete submission text file 0001193125-20-150209.txt   432979

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dvax-20200521.xsd EX-101.SCH 3066
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20200521_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20200521_pre.xml EX-101.PRE 11405
13 EXTRACTED XBRL INSTANCE DOCUMENT d934317d8k_htm.xml XML 3398
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 20906647
SIC: 2834 Pharmaceutical Preparations